Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
LAML | rs10587800 | chr6:127622141 | TACC/T | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs10588955 | chr6:127660919 | CAA/C | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs10631696 | chr17:39433308 | C/CCTT | 0.000125 | 110 | 0 | 19.23 | 13.15 | KM Plot |
LAML | rs10633704 | chr6:127650518 | A/ATT | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs10644705 | chr6:127707784 | T/TAGA | 1.86E-5 | 111 | 0.98 | 16.27 | 15.17 | KM Plot |
LAML | rs10700206 | chr2:241405400 | C/CGTG | 6.96E-6 | 106 | 1.03 | 11.62 | 19.23 | KM Plot |
LAML | rs10740831 | chr10:31015182 | A/G | 0.000176 | 111 | 1 | 6.58 | 16.2 | KM Plot |
LAML | rs10744555 | chr12:1949463 | T/C | 0.00017 | 107 | 0 | 20.27 | 12.2 | KM Plot |
LAML | rs10745291 | chr10:134976554 | C/T | 4.34E-5 | 111 | 16.3 | 19.33 | 3 | KM Plot |
LAML | rs10765610 | chr11:93150836 | T/G | 5.99E-5 | 110 | 6.13 | 14.13 | 16.3 | KM Plot |
LAML | rs10779924 | chr2:39208057 | G/T | 0.000134 | 111 | 0 | 5.57 | 16.27 | KM Plot |
LAML | rs10831035 | chr11:93150392 | G/C | 5.23E-5 | 111 | 6.13 | 14.13 | 16.27 | KM Plot |
LAML | rs10831036 | chr11:93150394 | G/A | 5.23E-5 | 111 | 6.13 | 14.13 | 16.27 | KM Plot |
LAML | rs10831044 | chr11:93161528 | A/G | 5.99E-5 | 110 | 6.13 | 14.13 | 16.3 | KM Plot |
LAML | rs10857671 | chr10:134965099 | C/T | 2.85E-5 | 110 | 16.3 | 19.8 | 3 | KM Plot |